MEDICALGORITHMICS SA redefines US sales strategy and strengthens team
Kardiolytics, subsidiary of Medicalgorithmics corporate group, was granted a patent (US 11521322 B2) for machine learning based segmentation of contrast filled coronary artery vessels on medical images.
MEDICALGORITHMICS SA redefines US sales strategy and strengthens team
On December 6, 2022, Medicalgorithmics’ Management Board adopted a sales strategy for the US market. The strategy is aimed at securing and accelerating long-term growth in the US and increasing market share. In addition to distribution of the full range of services, i.e. access to the PocketEKG platform with the Company’s latest algorithmics and delivery […]